Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil®)

Total article views   HTML views PDF downloads Totals
10,101 Dovepress* 10,101+ 1,839 11,940
Totals 10,101 1,839 11,940
*Since 8 February 2008
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on Google Scholar